At the same time, the regulator did not recognize the single-dose Sputnik Lite vaccination course.
The Therapeutic Goods Authority of Australia (TGA) on Monday, January 17, recommended that the Australian government allow entry to citizens vaccinated with two doses of the Russian COVID drug Sputnik V.
The corresponding message was published on the website of the Australian regulator.
It is noted that the two-dose course of vaccination “Sputnik V” will be “recognized” in order to determine the status of the traveler's vaccination.
“Last week, the TGA received additional information demonstrating that this vaccine provides protection and potentially reduces the chance that an incoming traveler will transmit a COVID-19 infection to others while in Australia or become acutely ill,” the TGA said.
According to the regulator, the supporting information is “based on published research provided to the TGA by the Russian government with the assistance of the Australian Embassy in Moscow.”
“The data showed that two doses of Sputnik V have an average efficacy against symptomatic infection of 89% and hospitalization or death of 98-100%,” the report said. At the same time, the TGA did not recognize the single-dose Sputnik Lite vaccination course.
“Sputnik's recognition will enhance the return of international students, the travel of skilled and unskilled workers to Australia, and the travel of business people and athletes to our country,” the Australian regulator said.
